What is the recommended prednisone taper for allergic urticaria (hives)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prednisone Taper Recommendation for Allergic Urticaria

For allergic urticaria (hives), a short tapering course of oral prednisone starting at 0.5-1 mg/kg/day for 3-7 days followed by a gradual taper over 1-2 weeks is recommended when antihistamines fail to control symptoms. 1, 2

Initial Dosing

  • Oral prednisone may shorten the duration of acute urticaria at a dose of 50 mg daily for 3 days in adults, though lower doses are often effective 1
  • For severe or widespread hives, prednisone at 0.5-1 mg/kg/day is appropriate until symptoms improve to mild or resolve 2, 3
  • Antihistamines should be continued during the corticosteroid course as the primary treatment 4

Recommended Tapering Schedule

  • Days 1-5: Full prescribed dose (typically 0.5-1 mg/kg/day) 2
  • Days 6-7: Reduce to 75% of original dose 2
  • Days 8-9: Reduce to 50% of original dose 2
  • Days 10-11: Reduce to 25% of original dose 2
  • Day 12: Discontinue 2

Alternative Tapering Approach

For more severe cases requiring longer treatment:

  • Start with prescribed dose (0.5-1 mg/kg/day) for 3-7 days 1, 3
  • Reduce by 5-10 mg every 1-2 days until reaching 20 mg 1
  • Then reduce by 5 mg weekly until reaching 10 mg 1
  • Finally, reduce by 2.5 mg weekly until discontinuation 1

Important Considerations

  • Long-term oral corticosteroids should not be used in chronic urticaria except in very selected cases under specialist supervision 1, 4
  • Brief courses of steroids (3-10 days) can be employed for severe exacerbations but should be an infrequent occurrence 4
  • Corticosteroid-related side effects include facial rounding, weight gain, acne, and with prolonged use: osteopenia, diabetes, and hypertension 1
  • In a study of antihistamine-resistant urticaria, a short course of prednisone (starting at 25 mg/day for 3 days) induced remission in nearly 50% of patients 5

Treatment Algorithm

  1. First-line: Second-generation antihistamines (up to 4 times the standard dose) 4, 6
  2. If inadequate response after 2-4 weeks: Add short course of prednisone with taper as outlined above 1, 2
  3. For recurrent/chronic cases unresponsive to the above: Consider omalizumab or referral to specialist 4
  4. Monitor for side effects during treatment, particularly if courses are repeated 1

Special Populations

  • For children with urticaria: Prednisone 1-2 mg/kg daily (up to 60 mg/day) with taper over 6-8 weeks to 0.1-0.2 mg/kg daily or 5 mg daily 1
  • For pregnant patients: Avoid all antihistamines if possible, especially during the first trimester; if corticosteroids are necessary, consult with an obstetrician 1, 3

Remember that corticosteroids should not be the primary treatment for urticaria but rather an adjunct for severe symptoms when antihistamines fail to provide adequate relief 1, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Corticosteroid Tapering for Dermatologic Conditions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Full Body Rash with Short Course of Prednisone

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Chronic Spontaneous Urticaria: Pathogenesis and Treatment Considerations.

Allergy, asthma & immunology research, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.